Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data

by Tougher S, the ACTwatch Group, Ye Y, Amuasi JH, Diap G, et al. The Lancet, October 31 2012, 6(11): e1870.

Click to read article